Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications
Jacopo Millul, Gabriele Bassi, Jacqueline Mock, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 16
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments
Zhennan Yuan, Yingpu Li, Sifan Zhang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 375
FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease
Yuriko Mori, Katharina Dendl, Jens Cardinale, et al.
Radiology (2023) Vol. 306, Iss. 2
Closed Access | Times Cited: 185
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
Dirk Zboralski, Aileen Hoehne, Anne Bredenbeck, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 11, pp. 3651-3667
Open Access | Times Cited: 135
Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review
Lei Xin, Jinfang Gao, Ziliang Zheng, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 116
Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond
Mengting Li, Muhsin H. Younis, Yongxue Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 8, pp. 2844-2868
Open Access | Times Cited: 81
FAPI PET/CT Imaging—An Updated Review
Kunal Ramesh Chandekar, Arun Prashanth, Sobhan Vinjamuri, et al.
Diagnostics (2023) Vol. 13, Iss. 12, pp. 2018-2018
Open Access | Times Cited: 53
Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA
Philipp Backhaus, F. Gierse, Matthias C. Burg, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 49, Iss. 6, pp. 1822-1832
Open Access | Times Cited: 69
Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling
Pei‐Yu Chen, Wen-Fei Wei, Hong-Zhen Wu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 61
[68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity
Zachary T. Rosenkrans, Christopher Massey, Ksenija Bernau, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 11, pp. 3705-3716
Open Access | Times Cited: 61
Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides
Jacopo Millul, Lennart Koepke, Gaonkar Raghuvir Haridas, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 10, pp. 3050-3061
Open Access | Times Cited: 37
Clinical Advances and Perspectives in Targeted Radionuclide Therapy
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1733-1733
Open Access | Times Cited: 34
Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis
Hongyan Qian, Chaoqiong Deng, Shiju Chen, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 14
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides
Richard P. Baum, Emil Novruzov, Tianzhi Zhao, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 4, pp. 537-556
Closed Access | Times Cited: 12
Small Molecule‐Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs
Jingjing Zhang, Fanchun Hu, Ömer Aras, et al.
ChemMedChem (2024) Vol. 19, Iss. 11
Closed Access | Times Cited: 10
Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)
Yuriko Mori, Emil Novruzov, Dominik Schmitt, et al.
npj Imaging (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 10
Preclinical and First-In-Human Imaging of Novel [18F]F-FAPI-FUSCC-07 Tracer: Comparative Prospective Study with [18F]F-FAPI-42 and [18F]F-FAPI-74
Linjie Bian, Xinyu Liu, Xiao Wang, et al.
Molecular Pharmaceutics (2025)
Closed Access | Times Cited: 1
FAP-targeted delivery of radioiodinated probes: A progressive albumin-driven strategy for tumor theranostics
Huifeng Li, Dongsheng Xia, Lingxin Meng, et al.
Journal of Controlled Release (2025), pp. 113678-113678
Closed Access | Times Cited: 1
Near‐Infrared Organic Room Temperature Phosphorescent Probes Targeting Fibroblast Activation Protein for Surgical Navigation of Liver Cancer
Jinghua Li, Juqing Gu, Liangxuan Ding, et al.
Aggregate (2025)
Open Access | Times Cited: 1
Radioligands Targeting Fibroblast Activation Protein (FAP)
Thomas Lindner, Frederik L. Giesel, Clemens Kratochwil, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5744-5744
Open Access | Times Cited: 53
New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress
Surachet Imlimthan, Euy Sung Moon, Hendrik Rathke, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1023-1023
Open Access | Times Cited: 47
A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake
Andrea Galbiati, Aureliano Zana, Matilde Bocci, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. 12, pp. 1852-1858
Open Access | Times Cited: 35
Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein
Lingxin Meng, Jianyang Fang, Liang Zhao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 12, pp. 8245-8257
Closed Access | Times Cited: 35
Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation
Juan Sun, Zhenyuan Huangfu, Jiangtao Yang, et al.
Advanced Drug Delivery Reviews (2022) Vol. 190, pp. 114538-114538
Closed Access | Times Cited: 34
Rational Design and Pharmacomodulation of 18F-Labeled Biotin/FAPI-Conjugated Heterodimers
Xuedong Chen, Dongsheng Xia, Xueyuan Zeng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 8361-8371
Closed Access | Times Cited: 8
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging
Rita Saúde-Conde, Ayça Arçay, Kosta Stosic, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 591-591
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top